Effects of rising malpractice premiums said to be overstated












A recent report by the U.S. General Accounting Office caused much discussion recently by challenging the contention that physicians are moving out of states in which medical malpractice insurance premiums have risen steeply. The GAO found that "many of the reported provider actions were not substantiated or did not affect access to health care on a widespread basis."

Health plans worried that the malpractice crisis may begin to affect access to physicians for their members may breathe a bit more easily, though there is still some cause for concern. Officials in two states, Nevada and West Virginia, dispute the report's findings, saying it did not weaken any of the arguments for medical liability reform. The GAO did find that malpractice premiums rose more slowly in states that placed caps on damages for pain and suffering.

Premium growth lower when caps on damages exist

*Note: Excludes states with caps of $250,000.

SOURCE: UNITED STATES GENERAL ACCOUNTING OFFICE, MEDICAL MALPRACTICE: IMPLICATIONS OF RISING PREMIUMS ON ACCESS TO HEALTH CARE

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.